Sanford R Nalitt Institute For Cancer & Blood Related Diseases entered the industry of Oncologists in 1991 and has grown to employ 1 to 4 people, generating an annual revenue of $500.000 to $999.999. The NAICS classifies this business under the code 621111, which describes it as a Oncologists. For further clarification, the SIC classifies this business under the code 8011 and described it as a Oncologists. The business provides service to the B2C market.
To acquire more information, please contact Frank Forte by calling (718) 226-6400 during business hours. You can also write to the business’ Single Location at 256 Mason Avenue, Staten Island, New York NY 10305. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
Company: | Sanford R Nalitt Institute For Cancer & Blood Related Diseases |
Representative: | Frank Forte |
Place of Business: | 256 Mason Avenue, Staten Island, NY 10305 |
Contact Number: | (718) 226-6400 |
Type of Service: | Oncologists |
SIC Number: | 8011 |
NAICS Number: | 621111 |
Locality: | Single Location |
Market Type: | B2C (Business to Consumer) |
Began: | 1991 |
Income/Year: | $500.000 to $999.999 |
Laborers: | 1 to 4 |
Share This Company: |
Sanford R Nalitt Institute For Cancer & Blood Related Diseases is a company operating from Richmond, New York providing professional Oncologists and relevant B2C variables. It was founded in 1991 and registered with the SIC code 8011 as Oncologists, and with the NAICS code 621111 as Oncologists.
With a current employee count of 1 to 4, Sanford R Nalitt Institute For Cancer & Blood Related Diseases has gone to report making $500.000 to $999.999 per annum on its journey towards growth. This company invites you to contact its representative Frank Forte at (718) 226-6400 for related queries, or to locate its Single Location using the coordinates 40.58641,-74.086783.
The Single Location can also be found at the street address 256 Mason Avenue in Staten Island, New York 10305 and can be engaged online through the company website at , the company Twitter , and Facebook page .